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Abstract 
Few studies have explored the consequences of environmental exposure to organochlorine 
pesticides for gestational hypertension (GH), preeclampsia (PE) and gestational diabetes 
mellitus (GDM). Chlordecone is a persistent organochlorine pesticide that was used 
intensively, and almost exclusively, in the French West Indies until 1993. We investigated the 
impact of prenatal exposure to chlordecone on the occurrence of GDM, GH and PE by 
studying 779 pregnant women enrolled in a prospective mother-child cohort (Timoun study) 
in Guadeloupe between 2004 and 2007. Chlordecone exposure was determined by assaying 
maternal plasma and information about pregnancy complications was obtained from 
midwives, pediatricians and hospital medical records after delivery. The risks of GH (n = 65), 
PE (n = 31) and GDM (n = 71) were estimated by multiple logistic regression including 
potential confounders. Levels of chlordecone plasma concentration in the third (OR = 0.2; 
95% confidence interval (CI): 0.1, 0.5) and fourth quartiles (OR = 0.3; 95% CI: 0.2, 0.7) were 
associated with a statistically significant decrease in the risk of GH. A log10 increase in 
chlordecone concentration was significantly associated with lower risk of GH (OR = 0.4; 
95% CI: 0.2, 0.6). No significant associations were observed between chlordecone exposure 
and the risk of PE or GDM. This study suggests an inverse association between chlordecone 
exposure during pregnancy and GH. Further studies are required to determine the underlying 
mechanism, or the potential unknown confounding factors, resulting in this association.  
 
Key words: Chlordecone; Endocrine disruptor; Gestational diabetes; Gestational 
hypertension; Organochlorine pesticides; Preeclampsia  
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1. Introduction  
  
 Hypertensive disorders and diabetes mellitus are common problems a woman may 
experience during pregnancy (Olsen and Basso, 2005). These pregnancy complications are 
associated with significant short-term and long-term adverse health outcomes for both 
mothers and offspring. 
 Hypertensive disorders occur in 6% to 8% of pregnancies (National High Blood Pressure 
Education Program, 2000).  They include gestational hypertension (GH) and preeclampsia 
(PE). Gestational hypertension describes women who develop hypertension after 20 weeks of 
gestation without proteinuria (Leeman and Fontaine, 2008). In most cases, it does not 
compromise the pregnancy but may be a precursor sign of later chronic hypertension or lead 
to worse perinatal outcomes if the woman progresses to severe GH (defined as a substantial 
increase in blood pressure). The causes of most cases of GH remain unknown. Preeclampsia 
is a pregnancy-specific syndrome characterized by increased blood pressure accompanied by 
proteinuria. Is a major cause of maternal mortality and morbidity, perinatal death, preterm 
birth, and intrauterine growth restriction (Sibai et al., 2005).   
 The prevalence of gestational diabetes mellitus (GDM) may range from 1% to 14% of all 
pregnancies, depending on the population studied and the diagnostic test employed 
(American Diabetes Association, 2004). Overweight or obesity and ethnicity are recognized 
risk factors (Zhang and Ning, 2011). Women with GDM are at increased risk of perinatal 
morbidity, impaired glucose tolerance and type 2 diabetes in the years after pregnancy. 
Children of women with GDM are also more likely to be obese and have impaired glucose 
tolerance and diabetes in childhood and early adulthood (Zhang and Ning, 2011). 
 Several studies have investigated risk factors for the occurrence of these pregnancy 
complications. However, few have examined the contribution of environmental risk factors 
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such as pesticides, and in particular persistent organochlorine pesticides (OC). Recent reports 
from the Agricultural Health Study show an increased risk of self-reported GH, PE and GDM 
associated with residential or agricultural pesticide exposure during the first trimester of 
pregnancy (Saldana et al., 2007, 2009). In a recent population-based cohort in the 
Netherlands, no consistent associations between occupational exposure to chemicals, 
including pesticides, during pregnancy and hypertensive disorders were observed, but the 
frequency of exposure to chemicals in general and to pesticides in particular was very low 
(Nugteren et al., 2012). In a large cohort study of exposures of Norwegian farmers to 
immunomodulating substances, pesticide use was found to be associated with a moderate, but 
statistically significant, decrease in the risk of PE (Nordby et al., 2006). 
For OC exposure during pregnancy, an inverse association between exposure to p,p’-
dichlorodiphenyldichloroethylene (DDE), the main metabolite of dichlorodiphenyl 
trichloroethane, or to PCBs and GH and PE was identified by a large birth cohort study 
including 2,193 women (Savitz et al., 2013). In the general population, contradictory results 
have been found concerning exposure to OC pesticides and hypertension risk (Goncharov et 
al., 2011; Ha et al., 2009; Valera et al., 2013a, 2013b). We have been unable to find any study 
of the relationship between exposure to OC pesticides and GDM. Studies in the general 
population suggest that altered glucose metabolism, increased insulin resistance and reduced 
insulin production related to OC pesticide exposure may contribute to causing diabetes (Lee 
et al., 2006; Montgomery et al., 2008; Rylander et al., 2005). 
 The present study focuses on the population of Guadeloupe (French West Indies), which 
has been chronically exposed to chlordecone. Chlordecone is almost the only OC pesticide 
that was used, and extensively, in French West Indies to control banana root borers between 
the early 1970s and 1993. Chlordecone undergoes no significant biotic or abiotic degradation 
in the environment (Cabidoche et al., 2009; Faroon et al., 1995). As a consequence and 
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despite chlordecone prohibition in 1993, permanently polluted soils and waterways have 
been, and are still nowadays, the major sources of human contamination in French West 
Indies, through the consumption of contaminated and locally produced foodstuffs (Dubuisson 
et al., 2007; Guldner et al., 2010).  
 Studies on animals have documented that pre-gestational or gestational exposure of rats 
and mice to chlordecone affects embryo implantation and both prenatal and postnatal 
development (Faroon et al., 1995). The mechanism of the toxic action of chlordecone is not 
completely understood but it has been suspected that its hormonal properties and/or its effect 
on neurotransmission may be involved (Faroon et al., 1995).  
 Experimental studies have documented the toxic effects of chlordecone exposure during 
gestation in animals, but there has been no epidemiological study to determine if chlordecone 
has similar consequences in humans at environmentally relevant exposure levels.   The 
Timoun mother–child cohort study was established to investigate the consequences for 
pregnancy and child development of prenatal exposure to the widespread chlordecone 
pollution in the French West Indies. We recently reported an association between maternal 
exposure to chlordecone during pregnancy and an increased risk of preterm birth (Kadhel et 
al., 2014). Here, we report the relationships between maternal exposure to chlordecone and 
the risk of GH, PE and GDM. 
 
2. Methods 
2.1. Population and study design 
 The study population consisted of pregnant women enrolled in the Guadeloupean 
prospective epidemiological mother-child cohort study, Timoun, from November 2004 to 
December 2007. Women who had been living in Guadeloupe for at least 3 years were 
enrolled during the third-trimester prenatal visit to a Guadeloupe public hospital or 
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dispensary. Of the 1,068 women participants, we excluded women whose pregnancy ended in 
medical termination, fetal death or stillbirth (n=6), women whose babies had major 
congenital malformations according to the EUROCAT definitions (EUROCAT, 2005) 
(n=36), and women with missing data on pregnancy complications (n=34) or on chlordecone 
exposure measurements (n=213). The final analysis included 779 pregnant women. The study 
was approved by the Guadeloupean Ethics Committee for studies involving human subjects 
and each participant provided written informed consent. 
2.2. Exposure assessment   
 The chlordecone concentration in maternal blood samples collected into EDTA tubes 
during labor was determined. After centrifugation, the resulting plasma samples were 
transferred to polypropylene Nunc
®
 tubes and stored at -30°C. Plasma samples were 
transferred, in dry ice, to the Center for Analytical Research and Technology (Liège, 
Belgium) for determination of chlordecone concentrations by gas chromatography-electron 
capture detection. Preparation of samples and the quantification method were as previously 
described (Debier et al., 2003: Multigner et al., 2010), and details including quality control 
data are provided in Supplemental material. The limit of detection (LOD) of chlordecone was 
0.06 µg/L. Samples from a subgroup of 358 women were also assayed for DDE and PCB 153 
(Debier et al., 2003). The LOD for both compounds were 0.05 µg/L. Total cholesterol and 
triglyceride concentrations in plasma were determined by standard enzymatic procedures 
(DiaSys Diagnostic Systems GmbH, Holzheim, Germany) and total lipid concentrations were 
calculated as described elsewhere (Bernet et al., 2007) 
2.3. Pregnancy complications 
 Information about the medical history of the pregnancy was collected from midwives, 
pediatricians and hospital medical records after delivery. Participants were considered to have 
GH if they developed systolic blood pressure > 140 mm Hg and/or diastolic blood pressure ≥ 
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90 mm Hg after 20 weeks of gestation without proteinuria and if they were previously 
normotensive. PE was defined as GH associated with proteinuria > 0.3 g/L in a 24-hour urine 
sample (National High Blood Pressure Education Program, 2000). Women who were 
diagnosed with both GH and PE were assigned to the PE group. Women assigned to the GH 
group had GH alone. If hypertension was reported before pregnancy and/or it was detected 
before 20 weeks of gestation, the women were considered to have chronic hypertension and 
were included in the control group. Women were considered to have GDM if they had two or 
more abnormal glucose tolerance test results between 24 and 28 weeks of gestation 
(Carpenter and Coustan, 1982) and if they were previously normoglycemic. Pregnant women 
were systematically screened between 24 and 28 weeks of gestation with a fasting oral 
glucose tolerance test, in which venous blood was sampled 1 hour after oral loading with 100 
g glucose (American Diabetes Association, 2004). Normal results were a blood glucose <95 
mg/dL at baseline, <180 mg/dL at 1 hour, <155 mg/dL at 2 hours and <140 mg/dL at 3 hours. 
If diabetes was reported before pregnancy or an abnormal glucose test result was observed at 
the first prenatal visit (usually between 5 and 10 weeks of gestation), the women were 
considered to have a preexisting diabetes mellitus (this group included those with pre-
gestational diabetes mellitus) and were included in the control group.  
 
2.4. Statistical analysis 
 The odds ratio (OR) and 95% confidence intervals (CI) for the association between 
outcomes and chlordecone were estimated using multiple logistic regression. Polytomous 
logistic regression was used to estimate simultaneously the risks of non-ordered hypertensive 
disorders of pregnancy (GH, PE) versus a common control group (without GH and without 
PE). 
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 Regression models included the following potential confounders chosen a priori as 
being likely to interfere with the association between chlordecone exposure and outcome 
variables (see Table 1 and supplemental material, Table S1): maternal place of birth 
(Guadeloupe/Martinique, other Caribbean islands, Europe), place of enrolment (University 
hospital, local hospital, local antenatal care unit), maternal age (≤25, 26-31, 32-37, ≥38 
years), pre-pregnancy body mass index (BMI; in kg/m²; underweight or normal: <25, 
overweight: 25-<30, obese: >30) and average weekly weight gain during pregnancy 
categorized according to the median (in g/week) (< 340, ≥ 340). Because a substantial 
fraction of chlordecone is transported by lipids, all analyses were further adjusted for the total 
lipid concentration in maternal plasma (in g/L). Analyses were performed using chlordecone 
as a categorical variable (in quartiles, in µg/L) and as a log10-transformed continuous 
variable.  
 When chlordecone was analyzed as a categorical variable, exposure levels equal to or 
below the LOD were included in the first (lowest) quartile. In sensitivity analyses, we 
handled missing values for chlordecone (N = 213) using multiple imputation techniques 
(Little and Rubin, 1986; Rubin, 2008) implemented in the R mi package (Su et al., 2011). For 
the imputation procedure, we included the following predictors of exposure categories: case 
status, maternal place of birth, place of enrolment, education level, parity, maternal age, 
marital status, pre-pregnancy BMI, and weight gain during pregnancy. A total of five imputed 
datasets were generated and the main analyses were repeated. Final estimators of associations 
were then combined using the SAS Proc MIANALYZE procedure.  
 When chlordecone was analyzed as a continuous variable, we imputed values of 
chlordecone plasma concentrations below the LOD (12.4%) using the likelihood method (Jin 
et al., 2011), under the assumption that chlordecone concentration is log-normally distributed. 
When examining relations between outcomes and exposures considered as continuous 
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variables, simple substitution methods replacing values <LOD by 0, LOD/2, LOD or others, 
may lead to biased estimations when the percentage of non-detects is >15% (Baccarelli et al., 
2005; Whitcomb and Schisterman, 2008); consequently, the use of distribution-based 
multiple imputation is recommended (EPA, 2000). These methods have been shown to be 
able to produce unbiased estimations, even when the percentage of detected values is high 
(50% to 70%). Five datasets with imputed concentrations below the LOD were generated and 
analyzed, and the five estimations of associations were then combined using the SAS Proc 
MIANALYZE procedure. To identify the linear and/or non-linear components of the 
relationship between chlordecone exposure and pregnancy outcomes, we examined spline 
functions (with three knots at the quartiles of the distribution), using the SAS macro 
developed by Desquilbet and Mariotti (2010).  
 SAS software version 9.3 (SAS Institute Inc., Cary, North Carolina) and R version 
2.12.2 (http://www.r-project.org/) were used for analyses; all tests were two-sided, and P 
values < 0.05 were considered statistically significant. 
 
 
3. Results 
 The mean age of the 779 women included in the analysis was 31 years (range 12.4 to 
49.6); 77.8% were born in Guadeloupe or Martinique, 69.2% were enrolled at the 
Guadeloupe university hospital, and 40% were classified as overweight or obese before 
pregnancy. Overall, 8.3% of all women had GH and 4% PE. GDM was diagnosed in 9.1% of 
the women. Women with GH or GDM were more likely to be enrolled at the university 
hospital, to have been born on the other Caribbean islands, and to be older and obese (Table 
1). Women with PE were more likely to be nulliparous, to have multi-foetal pregnancies and 
to have a greater weight gain during pregnancy. The proportion of women who smoked 
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during their pregnancy was lower among those with either GH, PE or GDM. Chlordecone 
plasma concentration levels were above the LOD for 87.6% of the women and the median 
concentration was 0.4 µg/L (interquartile interval: 0.2-0.8). 
 Two hundred and eighty nine (27%) of the 1068 women eligible for inclusion in the 
cohort were excluded, in most cases because of missing chlordecone exposure data (N=213). 
Excluded women were more likely than included women to have been born in the French 
West Indies or other Caribbean islands, to have a lower educational level and to have been 
enrolled at a local hospital. The frequencies of GH, PE and GDM among excluded women 
were 8.6%, 5.7% and 10.7%, respectively (see supplemental material, Table S2). 
 Crude and adjusted ORs for hypertensive disorders during pregnancy in relation to 
exposure to chlordecone are given in Table 2.  After adjustment for confounders, a negative 
association between chlordecone exposure and GH was detected: the decrease in OR was 
statistically significant for the third quartile (OR=0.2; 95% confidence interval (CI): 0.1, 0.5) 
and fourth quartile (OR= 0.3; 95% CI: 0.2, 0.6) of chlordecone plasma concentrations. When 
considering chlordecone as continuous variable, chlordecone concentration was significantly 
associated with a lower risk of GH (OR = 0.4; 95% CI: 0.2, 0.6). The study of the 
relationship between log-chlordecone blood concentrations and GH risk using splines 
revealed a significant decreasing linear component (P<0.01), the non-linear component not 
being significant (P=0.37) (see supplemental material, Figure S1). In contrast, we found no 
significant association between chlordecone exposure during pregnancy and PE (Table 2).   
 There was no statistically significant association between chlordecone exposure during 
pregnancy and risk of GDM in both crude and adjusted models, although a decreasing trend 
in risk with increasing plasma chlordecone concentration was observed (Table 3).  
 The comparison of the associations obtained when considering complete cases (N = 779) 
(Tables 2 and 3) or all subjects with missing chlordecone values imputed (N = 992) 
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(supplemental material, Table S3) shows that imputation attenuated the slope of decreased 
risk of GH, but the decreasing trend in risk remained statistically significant. For PE and 
GDM, the results were less sensitive to the inclusion of imputed values for missing 
chlordecone measurements. 
 In the subgroup of 358 women for whom DDE and PCB 153 concentrations were 
assayed, Spearman’s rank correlation coefficients were 0.02 (P = 0.75) between chlordecone 
and DDE, and -0.02 (P = 0.76) between chlordecone and PCB 153. There is thus no evidence 
suggesting that DDE and PCB 153 are confounders in these associations. 
 
4. Discussion 
 This study conducted in a population of pregnant women chronically exposed to 
chlordecone suggests an inverse association between chlordecone exposure during pregnancy 
and GH risk. Conversely, we found no statistically significant association between 
chlordecone exposure and PE or GDM. 
 These results were obtained by studying a population chronically exposed to 
chlordecone through the consumption of contaminated locally produced foodstuffs such as 
root vegetables.  In the French West Indies, DDT has not been extensively used in agriculture 
or for disease vector control. In addition, this territory has had only very limited industrial 
activities involving significant use or emission of PCBs. Consequently, exposure to these 
chemical pollutants is likely to be the consequence of the universal atmospheric transport 
from remote areas and background contamination of the food chain. The poor correlation we 
found between chlordecone plasma concentration and other OCs chemicals may be explained 
by the different sources of exposure.   
 Chlordecone has not been measured in populations other than those in the French West 
Indies (Boucher et al., 2013; Dallaire et al., 2012; Guldner et al., 2010; Kadhel et al., 2014; 
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Multigner et al., 2010) and Hopewell (Virginia, USA) (Cannon et al., 1978; Cohn et al., 
1978).  A chlordecone poisoning episode in Hopewell affected plant workers during the mid-
1970s. This led to a very high exposure, resulting in blood concentrations one hundred to one 
thousand times greater than those currently observed among the French West Indian 
population. Chlordecone exposure was also measured among adult residents of Hopewell 
during the mid-1970s and the serum concentrations in subjects with detectable values (at this 
time the LOD was around 1.5 µg/L) was between 5 and 32 µg/L (Cannon et al., 1978), a 
range similar to those currently observed in French West Indies population.   
 Very few studies have been conducted in this domain. The major epidemiological 
studies that investigated the effects of pesticides on pregnancy-related hypertensive disorders 
and GDM examined the consequences of occupational or residential exposure to these agents. 
In these studies, pesticide exposure was frequently nonspecific, or the pesticides belonged to 
chemical families with particular properties, different from chlordecone (Nordby et al., 2006; 
Nugteren et al., 2012; Saldana et al., 2007, 2009; Willis et al., 1993). A recent report 
described the relationship between serum levels of persistent OC measured during the third 
trimester of pregnancy and the development of GH and PE, among 2,193 women included in 
a large birth cohort study in the United States (Savitz et al., 2013). The authors found an 
inverse association between exposure to DDE or PCBs, and GH and PE, and the association 
was stronger for PE. Other studies on the risk of hypertension were conducted in the general 
population exposed to OC pesticides, and report conflicting results (Goncharov et al., 2011; 
Ha et al., 2009; Valera et al., 2013a, 2013b). These studies represent a pathophysiological 
context different than hypertensive disorders of pregnancy. Thus, the body of evidence 
relevant to the association between OC pesticides and hypertensive disorders of pregnancy is 
limited, and therefore our findings should be interpreted with caution. 
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 There are several modes of action of chlordecone that could explain the inverse 
association with the risk of GH. Animal studies have shown that chlordecone exposure 
affects centrally regulated functions through noradrenaline-mediated effects (Chen et al, 
1985; Tilson et al, 1987). Additional studies in rats have shown that chlordecone induces 
hypothermia mediated by alterations in alpha-adrenergic nervous system (Cook et al., 1987, 
1988a, 1988b; Swanson and Wooley, 1982). Both the regulation of central body temperature 
and the control of vascular tone regulating blood pressure are under the influence of 
adrenergic mechanisms in the sympathetic arm of the autonomic nervous system. 
Unfortunately, blood pressure measurements were not reported in any of the studies cited 
above. It has not been established whether or not chlordecone acts on the regulation of blood 
pressure in the same way and direction as on the central temperature. Another possible 
mode of action is related to the endocrine disrupting properties of chlordecone with 
progestagenic-like characteristics. Chlordecone stimulates the synthesis of the progesterone 
receptor in rat uterine tissues in vivo (Hammond et al., 1979), and can inhibit the binding of 
the progestin agonist R5020 to the form A of the progesterone receptor in vitro (Vonier et al., 
1996). Progesterone also has hypotensive properties (Rylance et al., 1985) and the 
progesterone receptor in vascular smooth muscle cells has been identified as a target 
(Falkenstein et al., 1996). These observations raise the possibility that the observed inverse 
association between exposure to chlordecone and risk of GH may be due to the 
sympathomimetic and/or progestin properties of chlordecone. 
 However, the possibility of reverse causation cannot be excluded: GH may affect the 
chlordecone concentration in blood. Indeed, during pregnancy there is a physiological 
increase in plasma volume (Letsky, 2008), and this could lead to a dilution of chlordecone in 
the plasma of pregnant women. Nevertheless, GH does not cause specific changes in plasma 
volume compared to normotensive pregnant women (Silver et al., 1998), and the mechanisms 
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through which blood pressure may influence the chlordecone concentration in blood, if any, 
are unclear.  
 The possible influence of other, unknown, determinants that may be associated with both 
plasma chlordecone concentrations and GH should also be considered. Savitz et al. (2013) 
raised the possibility that renal dysfunction and/or hypertriglyceridemic dyslipidemia may 
distort the association observed between DDE or PCB exposure and GH or PE. However, this 
is not fully coherent with the fact that we found no significant association between 
chlordecone exposure during pregnancy and PE: both renal impairment and dyslipidemia are 
more likely in cases of PE than GH (Franz & Wendler, 1992; Gallos et al, 2013; Wang et al, 
2013).  
 The main strengths of this study lie in its design, a population-based cohort study, and 
the exposure and outcome measurements. Chlordecone exposure was determined with 
maternal plasma samples, providing an accurate reflection of the load of this compound in the 
body (Cohn et al., 1978; Guzelian, 1982). Its half-life in blood is around 6 months (Cohn et 
al., 1978), so a single measure at the end of pregnancy can be considered to be reasonably 
representative of exposure throughout the pregnancy. Co-exposures to other OC compounds 
were also considered (DDE and PCB153). Data for pregnancy complications were collected 
from obstetricians participating in the cohort study, which enhances their reliability. Also, the 
known risk factors for GH, PE or GDM were found. The small numbers in some of the 
groups may however have limited our capacity to uncover associations with PE in particular. 
 
5. Conclusion 
 This study suggests a possible inverse association between chlordecone exposure during 
pregnancy and GH but no relationship with PE or GDM. Additional studies are necessary to 
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explore the mechanisms involved, and in parallel to identify putative unknown confounding 
factors that may affect this association. 
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